SPC396
Lungnahnettlu-fjölsykru sermigerð 22F sem er samtengt við CRM197 burðarprótín
Status:
UmsóknApplication date:
29.7.2022Application published:
15.8.2022
Max expiry date:
14.2.2037Medicine name:
ApexxnarMedicine for children:
No
Timeline
Today
29.7.2022Application
15.8.2022Publication
14.2.2037Expires
Marketing license
IS authorization number:
EU/1/21/1612/001-006Date:
22.2.2022
Foreign authorization number:
EU/1/21/1612Date:
14.2.2022
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3096785